Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2025-12-25 @ 7:26 PM
Study NCT ID:
NCT00778232
Status:
COMPLETED
Last Update Posted:
2008-10-23
First Post:
2008-10-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions
Sponsor:
Ranbaxy Laboratories Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-10
Start Date Type:
None
Primary Completion Date:
2002-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-22
First Submit QC Date:
None
Study First Post Date:
2008-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-10-22
Last Update Post Date:
2008-10-23
Last Update Post Date Type:
ESTIMATED